1. Introduction {#sec1}
===============

*Scedosporium* spp. is one of the species of the opportunistic pathogenic fungi that can always be found in environment, especially in sewerage. It infects immunocompromised patients and drowning men, involving lungs, sinuses, bones, joints, eyes, and brain \[[@B1]\].

In recent years, members of the genus*Scedosporium* are increasingly recognized as opportunistic agents of disease, for example, in transplant recipients.*Scedosporium* species have been identified as the second most prevalent mold after*Aspergillus* colonizing the lungs of patients with cystic fibrosis \[[@B2]\].*Scedosporium* infections occur worldwide. In European countries, USA and Australia,*Scedosporium* species were always found in patients with chronic lung diseases, cystic fibrosis (CF), lung or allogenic bone-marrow transplantation, and hematologic malignancies \[[@B1], [@B3], [@B4]\]. Accordingly, the common types were pulmonary, nasal sinuses, skin/soft tissues, CNS, and disseminated infection \[[@B1], [@B3], [@B4]\].

It is traditionally recognized that*Pseudallescheria boydii* is the sexual stage of the*S. apiospermum*. However, recent molecular studies \[[@B5]--[@B7]\] showed that*Scedosporium* is a species complex comprising at least five distinct groups:*S. aurantiacum*,*P. minutispora*,*S. dehoogii*,*S. apiospermum*, and*P. boydii*, the last group consisting of four closely related subgroups called*P. boydii*,*P. angusta*,*P. ellipsoidea*, and*P. fusoidea.* Furthermore,*S. prolificans* is now renamed as*Lomentospora prolificans* \[[@B8]\]. It is important to identify*Scedosporium* spp. to species level because their virulence, metabolic trait, and*in vitro* susceptibility may be various based on their different species \[[@B3]--[@B9]\].

2. Materials and Methods {#sec2}
========================

2.1. Strains {#sec2.1}
------------

From 1990 to 2014, twenty-one*Scedosporium* strains isolated from patients were reserved in Research Center for Medical Mycology at Peking University. The clinical samples were collected from 14 Chinese hospitals which located mainly in central and south of China. All the isolates were identified as*S. apiospermum* or*P. boydii* by morphology. A total of 23 isolates (including two strains from Japan) as shown in [Table 1](#tab1){ref-type="table"} were investigated in this study. Furthermore,*in vitro* susceptibility was performed on the same set strains.

2.2. Molecular Studies {#sec2.2}
----------------------

The isolates were cultured on PDA at 28°C for 7 days. For fungal DNA extraction, glass beads method previously described by van Burik et al. was followed \[[@B10]\]. Adapted from earlier genotyping studies \[[@B11]--[@B14]\], PCR amplification with different primer pairs was attempted for*Scedosporium* species for the following genes: *β*-tubulin (BT2, exons 2--4) \[[@B11]\], calmodulin (CAL, exons 3--4) \[[@B12]\], the second largest subunit of RNA polymerase II (RPB) \[[@B13]\], superoxide dismutase (SOD), and actin (ACT) \[[@B14]\].

The PCR assay (25 *μ*L) included 2 *μ*L of fungal DNA extract, 1 *μ*M of each gene-specific primer, 2.5 mmol dNTP Mix 1 *μ*L, 10x PCR buffer 2.5 *μ*L, and LA Taq polymerase 0.25 *μ*L (Fermentas, St. Leon-Rot, Germany). The amplification for all targeted genes was performed in a Eppendorf PCR machine (AG22331) as follows: 5 min of initial denaturation at 95°C, followed by 35 cycles at 95°C for 30 s, gene-specific annealing temperature for 30 s, and 72°C for 1 min (for RPB2 the annealing time was 2.5 min). The PCR products were visualized by electrophoresis on a 1% (w/v) agarose gel. Both strands of the PCR fragments were sequenced using the above-mentioned primers. The consensus sequences were obtained using SeqMan (DNAStar-Lasergene, Madison, WI, USA) software. Newly obtained sequences were deposited in GenBank under accession numbers KP 981107 to KP 981221 ([Table 1](#tab1){ref-type="table"}). They were used to conduct alignment analysis for preliminary species identification in the NCBI genomic database (<http://blast.ncbi.nlm.nih.gov/>) and CBS database (<http://www.cbs.knaw.nl/>). The sequences were aligned using MUSCLE. For the maximum likelihood analysis, the distances between sequences were calculated using the best parameter model found by MEGA 6.0 6 (<http://www.megasoftware.net/>). A bootstrap analysis was conducted with 1000 replications.

2.3. Susceptibility Test {#sec2.3}
------------------------

The*in vitro* susceptibility of the 23*Scedosporium* isolates against four antifungal agents was evaluated by using the Clinical and Laboratory Standards Institute (CLSI) M38-A2 broth microdilution method \[[@B15]\]. The inocula suspensions were prepared in new sterile tubes and adjusted to 0.4−5 × 10^6^ colony-forming units per milliliter (CFU/mL) by counting spores in a hemocytometer and subsequently verifying them through quantitative colony counts on PDA plates. The nongerminated spore suspensions were diluted 1 : 100 in an RPMI 1640 to achieve a final inoculum concentration of 0.4--5 × 10^4^ CFU/mL. The following antifungal agents were used: voriconazole (VOR; Shouguang Fukang Pharmaceutical Co., Ltd., China), posaconazole (POS; Merck, Rahway, NJ, USA), itraconazole (ITR; Shouguang Pharm), and amphotericin B (AMB; Sigma-Aldrich Co., St. Louis, USA). They were all diluted in 100% dimethyl sulphoxide as a stock solution with a concentration of 1.600 mg/L. Final drug concentrations ranged from 16 to 0.03 mg/L for all the four drugs. The minimal inhibitory concentrations (MIC) endpoints were defined as the lowest concentration at which there was a complete inhibition of growth.*Aspergillus flavus* ATCC 204304 served as a quality control strain. The microtiter panels were incubated at 35°C and the results were read after 72 h. All tests were performed in triplicate on three different days.

3. Results {#sec3}
==========

3.1. Molecular Phylogeny {#sec3.1}
------------------------

We were able to amplify and sequence 470 bp, 645 bp, 935 bp, 775 bp, and 396 bp of the BT2, CAL, RPB, ACT, and SOD loci, respectively. Of the 3221 nucleotides sequenced, 209 (6.5%) were informative for parsimony in the different*Scedosporium* isolates. For identification, reference sequence of*Scedosporium* species available in public database were used including BT2 and CAL, but no sequences for RPB, SOD, and ACT were available. The sequences for BT2, CAL, RPB, SOD, and ACT yielded phylogenetic trees with the same topology (Figures [1](#fig1){ref-type="fig"} [](#fig2){ref-type="fig"} [](#fig3){ref-type="fig"} [](#fig4){ref-type="fig"}--[5](#fig5){ref-type="fig"}). In the combination phylogenetic trees based on BT2 and CAL ([Figure 6](#fig6){ref-type="fig"}), 23 strains in our study were reidentified to the species level according to the reference strains, which were analyzed in the Gilgado literature.*P. boydii* (9/23) and its closely related subtypes*P. ellipsoidea* (6/23),*P. fusoidea* (1/23), and*P. angusta* (1/23) were the most common, and the other 6 of 23 strains were identified as*S. apiospermum*.

The topology of the combined tree ([Figure 7](#fig7){ref-type="fig"}) of all five loci was similar to those observed in the trees of individual locus and the combined tree of BT2 and CAL. Four principal clades were obtained. The four clades were the*P. boydii* clade,*P. ellipsoidea* clade,*P. fusoidea*/*P. angusta* clade, and*S. apiospermum* clade.*P. fusoidea* and*P. angusta* always assemble together, and*P. boydii* and*P. ellipsoidea* were very closely related.*S. apiospermum* has the highest intraspecies variability (genetic distance = 0.008), which is comparable to the interspecies variability between*P. fusoidea* and*P. angusta* (genetic distance = 0.008).

3.2. *In Vitro* Susceptibility Test {#sec3.2}
-----------------------------------

The MIC values for the four antifungal agents examined by the CLSI M-38A2 microdilution method against the 23 strains are presented in [Table 2](#tab2){ref-type="table"}. VOR was the most active agent against all 23 strains with a MIC range from 0.25 to 1 *μ*g/mL and a 0.46 *μ*g/mL GM. POS was the second most active agent with MIC values of 2 or 4 *μ*g/mL. For ITR, the intraspecific diversity was obvious as most strains had a MIC between 2 and 4 *μ*g/mL, but five strains were higher at a MIC of 32 *μ*g/mL. AMB is the least effective with high MIC values ranging from 4 to 32 *μ*g/mL*in vitro*.

The MIC~50~ and MIC~90~ for the four antifungal agents against*P. boydii*,*P. ellipsoidea*, and*S. apiospermum* are presented in [Table 3](#tab3){ref-type="table"}. There were similar MIC~50~ and MIC~90~ for VOR, POS, or AMB of the three species above. For ITR, the MIC~90~ of*P. boydii* (4 *μ*g/mL) was lower than that of*P. ellipsoidea* (32 *μ*g/mL) and*S. apiospermum* (32 *μ*g/mL).

4. Discussions and Literature Review {#sec4}
====================================

Scedosporiosis is a rare infection in China. Sporadic cases of*Scedosporium* infection have been reported since 1990, but most cases were identified in recent years. We reviewed 39 cases reported in China from 1990 to 2013 \[[@B16]--[@B31]\]. We found that infection in the nasal sinuses (16 cases) was the most frequently involved location, followed by eye (13), CNS (5), lung (4), skin/soft tissues (2), arthritis or osteomyelitis (1), and disseminated infection (1). The risk factors included trauma, drowning, and a compromised immune system (bone marrow transplant or stem cell transplantation). Trauma is the most common risk factor for scedosporiosis in Chinese patients, as nearly half of these patients have trauma history. Because cystic fibrosis is extremely rare in the Chinese population, no scedosporiosis in CF was reported in China.

Based on molecular identification, we found that*P. boydii* complex and*S. apiospermum* were the only two species in our study. Actually,*P. boydii* and*S. apiospermum* demonstrated a closely phylogenetic relationship. This is also reflected by their undifferentiated morphological characteristics, assimilation of different sugars, and growth temperature (data not shown). In*P. boydii* complex, four closely related subgroups,*P. boydii* (9 strains),*P. ellipsoidea* (6 strains),*P. fusoidea* (1 strain), and*P. angusta* (1 strain), were present in the study.

In a set of clinical and environmental strains from Austria, Germany, and Netherlands,*S. apiospermum* was the most prevalent, followed by*P. boydii* \[[@B32], [@B33]\]. In Australia,*S. apiospermum* and*S. aurantiacum* were the*Scedosporium* species with a high incidence except for*L. prolificans* \[[@B4]\]. Based on our study, we found that in China the*P. boydii* complex represents the most prevalent species (16/21) followed by*S. apiospermum* (5/21), which is the same as in Northern Spain and France \[[@B34], [@B35]\]. In the Chinese strains, we could not find*S. aurantiacum*, which had a high incidence in Australia and a relatively low incidence in Europe.

Antifungal susceptibility profiles for clinical breakpoint of*Scedosporium* species are still under study. Of the four antifungal tested in this study, VOR was found to be the most active agent against*Scedosporium* species; POS was the second, and AMB had limited antifungal activity. For ITR, the intraspecific diversity was obvious as the range of MIC from 2 to 32 *μ*g/mL and*P. boydii* had a lower MIC~90~ than that of*P. ellipsoidea* and*S. apiospermum.* This*in vitro* susceptibility data is consistent with previous reports \[[@B32], [@B34], [@B36]--[@B38]\]. In China, most cases caused by*Scedosporium* were treated with either ITR or VOR. Although*Scedosporium* strains have relatively high MIC values for ITR (GM = 5.25)*in vitro,* studies have verified that they are clinically effective \[[@B7]\].

5. Conclusion {#sec5}
=============

The*P. boydii* complex and*S. apiospermum* were the main*Scedosporium* species in clinical samples in China.*Scedosporium* species can be distinguished unambiguously by all the five loci in this study. VOR is the most active agent*in vitro* against the set of*Scedosporium* species in this study, followed by POS and ITR.
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###### 

Origin, sequence data, and species identification of studied isolates.

  BMU number   Clinical sample   GenBank accession number   Molecular identification                                    
  ------------ ----------------- -------------------------- -------------------------- ---------- ---------- ---------- ------------------
  00488        Unknown           KP981202                   KP981130                   KP981185   KP981153   KP981107   *P. boydii*
  00491^*∗*^   Unknown           KP981214                   KP981131                   KP981179   KP981154   KP981108   *S. apiospermum*
  01112        Unknown           KP981203                   KP981132                   KP981192   KP981155   KP981109   *P. boydii*
  01113        Unknown           KP981204                   KP981133                   KP981181   KP981156   KP981110   *P. boydii*
  01114        Unknown           KP981199                   KP981134                   KP981193   KP981157   KP981111   *P. boydii*
  01115        Unknown           KP981200                   KP981135                   KP981194   KP981158   KP981112   *P. angusta*
  01116        Unknown           KP981201                   KP981136                   KP981186   KP981159   KP981113   *P. boydii*
  01117        Eye ball          KP981205                   KP981138                   KP981180   KP981160   KP981114   *S. apiospermum*
  01118        Unknown           KP981215                   KP981137                   KP981190   KP981161   KP981115   *P. ellipsoidea*
  01272        Sputum            KP981206                   KP981139                   KP981182   KP981162   KP981116   *P. boydii*
  01297^*∗*^   Unknown           KP981221                   KP981140                   KP981195   KP981163   KP981117   *P. fusoidea*
  02948        Nasal sinus       KP981211                   KP981141                   KP981196   KP981164   KP981118   *P. boydii*
  03882        Sputum            KP981207                   KP981142                   KP981176   KP981165   KP981119   *S. apiospermum*
  04111        Joint fluid       KP981219                   KP981143                   KP981178   KP981166   KP981120   *S. apiospermum*
  04729        BALF              KP981216                   KP981144                   KP981198   KP981167   KP981121   *S. apiospermum*
  04730        Nasal sinus       KP981217                   KP981145                   KP981191   KP981168   KP981122   *P. ellipsoidea*
  04772        CSF               KP981220                   KP981146                   KP981183   KP981169   KP981123   *P. ellipsoidea*
  04780        BALF              KP981218                   KP981147                   KP981187   KP981170   KP981124   *P. ellipsoidea*
  05145        Unknown           KP981213                   KP981148                   KP981189   KP981171   KP981125   *P. ellipsoidea*
  07108        Sputum            KP981208                   KP981149                   KP981188   KP981172   KP981126   *P. ellipsoidea*
  07224        Brain             KP981209                   KP981150                   KP981184   KP981173   KP981127   *P. boydii*
  07374        Pus               KP981212                   KP981151                   KP981197   KP981174   KP981128   *P. boydii*
  07462        CSF               KP981210                   KP981152                   KP981177   KP981175   KP981129   *S. apiospermum*

^**∗**^Strains from Japan.

###### 

*In vitro* susceptibility of 23 *Scedosporium* strains studied in this paper.

  Strain species     Strain ID number   MIC (*μ*g/mL)             
  ------------------ ------------------ --------------- ---- ---- ----
  *P. boydii*        BMU 00488          0.25            2    4    4
  BMU 01112          0.25               2               2    32   
  BMU 01113          0.25               4               4    32   
  BMU 01114          0.5                2               4    8    
  BMU 01116          0.5                2               4    4    
  BMU 01272          0.5                2               2    8    
  BMU 02948          0.5                2               2    4    
  BMU 07224          0.25               2               4    16   
  BMU 07374          0.25               2               4    4    
                                                                  
  *P. ellipsoidea*   BMU 01118          1               4    32   4
  BMU 04730          0.5                2               2    4    
  BMU 04772          0.5                4               32   32   
  BMU 04780          0.5                4               4    16   
  BMU 05145          0.5                4               32   8    
  BMU 07108          0.25               4               4    8    
                                                                  
  *P. angusta*       BMU 01115          0.5             2    4    8
                                                                  
  *P. fusoidea*      BMU 01297          0.5             2    2    32
                                                                  
  *S. apiospermum*   BMU 00491          0.5             4    4    4
  BMU 01117          0.5                4               4    8    
  BMU 03882          0.5                2               4    8    
  BMU 04111          1                  4               32   16   
  BMU 04729          0.5                2               2    8    
  BMU 07462          1                  2               32   8    

###### 

The MIC~50~ and MIC~90~ for the four antifungal agents against *P*. *boydii*, *P*. *ellipsoidea*, and *S*. *apiospermum*.

  Species (number of isolates)   Drug concentration (*μ*g/mL)                              
  ------------------------------ ------------------------------ ----- --- --- --- ---- --- ----
  *P*. *boydii*(9)               0.25                           0.5   2   4   4   4    8   32
  *P*. *ellipsoidea* (6)         0.5                            1     4   4   4   32   8   32
  *S*. *apiospermum* (6)         0.5                            1     2   4   4   32   8   16
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